OpenURL Connection Search

Select item for more details and to access through your institution.

A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms.
Published in:
Neuroendocrinology, 2020, v. 110, n. 5, p. 377, doi. 10.1159/000502383
By:
- Al-Toubah, Taymeyah;
- Schell, Michael J.;
- Cives, Mauro;
- Zhou, Jun-Min;
- Soares, Heloisa P.;
- Strosberg, Jonathan R.
Publication type:
Article
The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine Neoplasms.
Published in:
Neuroendocrinology, 2020, v. 110, n. 3/4, p. 234, doi. 10.1159/000501126
By:
- Xie, Hao;
- Liu, Junjia;
- Yadav, Siddhartha;
- Keutgen, Xavier M.;
- Hobday, Timothy J.;
- Strosberg, Jonathan R.;
- Halfdanarson, Thorvardur R.
Publication type:
Article
Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS).
Published in:
Neuroendocrinology, 2018, v. 107, n. 1, p. 32, doi. 10.1159/000488394
By:
- Singh, Simron;
- Chan, David L.;
- Pavlakis, Nick;
- Moody, Lesley;
- Segelov, Eva;
- Metz, David C.;
- Strosberg, Jonathan R.
Publication type:
Article
Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.
Published in:
Neuroendocrinology, 2015, v. 101, n. 4, p. 274, doi. 10.1159/000430816
By:
- Koumarianou, anna;
- Kaltsas, Gregory;
- Kulke, Matthew H.;
- Oberg, Kjell;
- Strosberg, Jonathan R.;
- Spada, Francesca;
- Galdy, Salvatore;
- Barberis, Massimo;
- Fumagalli, Caterina;
- Berruti, alfredo;
- Fazio, Nicola
Publication type:
Article
Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors.
Published in:
Cancers, 2024, v. 16, n. 15, p. 2703, doi. 10.3390/cancers16152703
By:
- Alayli, Adam;
- Ngo, Hoang;
- Sikaria, Dhiraj;
- Ahmed, Altan;
- Salloum, Elias;
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah E.;
- Kis, Bela;
- Haider, Mintallah;
- El-Haddad, Ghassan
Publication type:
Article
Cardiac Magnetic Resonance for Diagnosis of Neuroendocrine Tumor Metastases to the Right and Left Ventricles with Carcinoid Heart Disease.
Published in:
Case Reports in Cardiology, 2019, p. 1, doi. 10.1155/2019/8746413
By:
- Barnebee, Daniel;
- Morse, Brian;
- Strosberg, Jonathan R.;
- Pejic, Marijan;
- Jeong, Daniel
Publication type:
Article
EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms.
Published in:
International Journal of Cancer, 2023, v. 153, n. 1, p. 164, doi. 10.1002/ijc.34499
By:
- Xiao, Zhiwen;
- Xu, Huaxiang;
- Strosberg, Jonathan R.;
- Lu, Renquan;
- Zhu, Xinzhe;
- Deng, Shengming;
- Ding, Lei;
- Ni, Quanxing;
- Warshaw, Andrew L.;
- Yu, Xianjun;
- Luo, Guopei
Publication type:
Article
EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumor.
Published in:
Cancer Genomics & Proteomics (1109-6535), 2019, v. 16, n. 5, p. 309, doi. 10.21873/cgp.20136
By:
- SALLER, JAMES;
- SEYDAFKAN, SHABNAM;
- SHAHID, MOHAMMAD;
- GADARA, MANOJ;
- CIVES, MAURO;
- ESCHRICH, STEVEN A.;
- BOULWARE, DAVID;
- STROSBERG, JONATHAN R.;
- AEJAZ, NASIR;
- COPPOLA, DOMENICO
Publication type:
Article
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials.
Published in:
2020
By:
- Vijayvergia, Namrata;
- Dasari, Arvind;
- Deng, Mengying;
- Litwin, Samuel;
- Al-Toubah, Taymeyah;
- Alpaugh, R. Katherine;
- Dotan, Efrat;
- Hall, Michael J.;
- Ross, Nicole M.;
- Runyen, Melissa M.;
- Denlinger, Crystal S.;
- Halperin, Daniel M.;
- Cohen, Steven J.;
- Engstrom, Paul F.;
- Strosberg, Jonathan R.
Publication type:
journal article
Sequencing of Somatostatin-Receptor-Based Therapies in Neuroendocrine Tumor Patients.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.265706
By:
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah;
- El-Haddad, Ghassan;
- Lagunes, Diane Reidy;
- Bodei, Lisa
Publication type:
Article
Sequencing of Somatostatin-Receptor--Based Therapies in Neuroendocrine Tumor Patients.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 340, doi. 10.2967/jnumed.123.265706
By:
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah;
- El-Haddad, Ghassan;
- Lagunes, Diane Reidy;
- Bodei, Lisa
Publication type:
Article
Sequencing of Somatostatin-Receptor--Based Therapies in Neuroendocrine Tumor Patients.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.265706
By:
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah;
- El-Haddad, Ghassan;
- Lagunes, Diane Reidy;
- Bodei, Lisa
Publication type:
Article
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258897
By:
- Strosberg, Jonathan R.;
- Srirajaskanthan, Rajaventhan;
- El-Haddad, Ghassan;
- Wolin, Edward M.;
- Chasen, Beth A.;
- Kulke, Matthew H.;
- Bushnell, David L.;
- Caplin, Martyn E.;
- Baum, Richard P.;
- Hendifar, Andrew E.;
- Öberg, Kjell;
- Ruszniewski, Philippe;
- Santoro, Paola;
- Broberg, Per;
- Leeuwenkamp, Oscar R.;
- Krenning, Eric P.
Publication type:
Article
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258897
By:
- Strosberg, Jonathan R.;
- Srirajaskanthan, Rajaventhan;
- El-Haddad, Ghassan;
- Wolin, Edward M.;
- Chasen, Beth A.;
- Kulke, Matthew H.;
- Bushnell, David L.;
- Caplin, Martyn E.;
- Baum, Richard P.;
- Hendifar, Andrew E.;
- Öberg, Kjell;
- Ruszniewski, Philippe;
- Santoro, Paola;
- Broberg, Per;
- Leeuwenkamp, Oscar R.;
- Krenning, Eric P.
Publication type:
Article
Reply: Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262340
By:
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah;
- El-Haddad, Ghassan
Publication type:
Article
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258897
By:
- Strosberg, Jonathan R.;
- Srirajaskanthan, Rajaventhan;
- El-Haddad, Ghassan;
- Wolin, Edward M.;
- Chasen, Beth A.;
- Kulke, Matthew H.;
- Bushnell, David L.;
- Caplin, Martyn E.;
- Baum, Richard P.;
- Hendifar, Andrew E.;
- Öberg, Kjell;
- Ruszniewski, Philippe;
- Santoro, Paola;
- Broberg, Per;
- Leeuwenkamp, Oscar R.;
- Krenning, Eric P.
Publication type:
Article
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258897
By:
- Strosberg, Jonathan R.;
- Srirajaskanthan, Rajaventhan;
- El-Haddad, Ghassan;
- Wolin, Edward M.;
- Chasen, Beth A.;
- Kulke, Matthew H.;
- Bushnell, David L.;
- Caplin, Martyn E.;
- Baum, Richard P.;
- Hendifar, Andrew E.;
- Öberg, Kjell;
- Ruszniewski, Philippe;
- Santoro, Paola;
- Broberg, Per;
- Leeuwenkamp, Oscar R.;
- Krenning, Eric P.
Publication type:
Article
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258897
By:
- Strosberg, Jonathan R.;
- Srirajaskanthan, Rajaventhan;
- El-Haddad, Ghassan;
- Wolin, Edward M.;
- Chasen, Beth A.;
- Kulke, Matthew H.;
- Bushnell, David L.;
- Caplin, Martyn E.;
- Baum, Richard P.;
- Hendifar, Andrew E.;
- Öberg, Kjell;
- Ruszniewski, Philippe;
- Santoro, Paola;
- Broberg, Per;
- Leeuwenkamp, Oscar R.;
- Krenning, Eric P.
Publication type:
Article
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258897
By:
- Strosberg, Jonathan R.;
- Srirajaskanthan, Rajaventhan;
- El-Haddad, Ghassan;
- Wolin, Edward M.;
- Chasen, Beth A.;
- Kulke, Matthew H.;
- Bushnell, David L.;
- Caplin, Martyn E.;
- Baum, Richard P.;
- Hendifar, Andrew E.;
- Öberg, Kjell;
- Ruszniewski, Philippe;
- Santoro, Paola;
- Broberg, Per;
- Leeuwenkamp, Oscar R.;
- Krenning, Eric P.
Publication type:
Article
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258897
By:
- Strosberg, Jonathan R.;
- Srirajaskanthan, Rajaventhan;
- El-Haddad, Ghassan;
- Wolin, Edward M.;
- Chasen, Beth A.;
- Kulke, Matthew H.;
- Bushnell, David L.;
- Caplin, Martyn E.;
- Baum, Richard P.;
- Hendifar, Andrew E.;
- Öberg, Kjell;
- Ruszniewski, Philippe;
- Santoro, Paola;
- Broberg, Per;
- Leeuwenkamp, Oscar R.;
- Krenning, Eric P.
Publication type:
Article
Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.242875
By:
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah;
- Pellè, Eleonora;
- Smith, Johnna;
- Haider, Mintallah;
- Hutchinson, Tai;
- Fleming, Jason B.;
- El-Haddad, Ghassan
Publication type:
Article
Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.242875
By:
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah;
- Pellè, Eleonora;
- Smith, Johnna;
- Haider, Mintallah;
- Hutchinson, Tai;
- Fleming, Jason B.;
- El-Haddad, Ghassan
Publication type:
Article
Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.242875
By:
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah;
- Pellè, Eleonora;
- Smith, Johnna;
- Haider, Mintallah;
- Hutchinson, Tai;
- Fleming, Jason B.;
- ElHaddad, Ghassan
Publication type:
Article
Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.242875
By:
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah;
- Pellè, Eleonora;
- Smith, Johnna;
- Haider, Mintallah;
- Hutchinson, Tai;
- Fleming, Jason B.;
- ElHaddad, Ghassan
Publication type:
Article
Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.242875
By:
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah;
- Pellè, Eleonora;
- Smith, Johnna;
- Haider, Mintallah;
- Hutchinson, Tai;
- Fleming, Jason B.;
- El-Haddad, Ghassan
Publication type:
Article
Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.242875
By:
- Strosberg, Jonathan R.;
- Al-Toubah, Taymeyah;
- Pellè, Eleonora;
- Smith, Johnna;
- Haider, Mintallah;
- Hutchinson, Tai;
- Fleming, Jason B.;
- Haddad, Ghassan El-
Publication type:
Article
Medical Management of Gastroenteropancreatic Neuroendocrine Tumors: Current Strategies and Future Advance.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.214882
By:
- Mohamed, Amr;
- Strosberg, Jonathan R.
Publication type:
Article
NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 7, p. 937, doi. 10.2967/jnumed.118.230607
By:
- Hope, Thomas A.;
- Abbott, Amanda;
- Colucci, Karen;
- Bushnell, David L.;
- Gardner, Linda;
- Graham, William S.;
- Lindsay, Sheila;
- Metz, David C.;
- Pryma, Daniel A.;
- Stabin, Michael G.;
- Strosberg, Jonathan R.
Publication type:
Article
Medical Management of Gastroenteropancreatic Neuroendocrine Tumors: Current Strategies and Future Advances.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 6, p. 721, doi. 10.2967/jnumed.118.214882
By:
- Mohamed, Amr;
- Strosberg, Jonathan R.
Publication type:
Article
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.
Published in:
Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 66, doi. 10.2967/jnumed.117.202275
By:
- Hope, Thomas A.;
- Bergsland, Emily K.;
- Bozkurt, Murat Fani;
- Graham, Michael;
- Heaney, Anthony P.;
- Herrmann, Ken;
- Howe, James R.;
- Kulke, Matthew H.;
- Kunz, Pamela L.;
- Mailman, Josh;
- May, Lawrence;
- Metz, David C.;
- Millo, Corina;
- O'Dorisio, Sue;
- Reidy-Lagunes, Diane L.;
- Soulen, Michael C.;
- Strosberg, Jonathan R.
Publication type:
Article
First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas.
Published in:
Cancer (0008543X), 2011, v. 117, n. 2, p. 268, doi. 10.1002/cncr.25425
By:
- Strosberg, Jonathan R.;
- Fine, Robert L.;
- Junsung Choi;
- Nasir, Aejaz;
- Coppola, Domenico;
- Dung-Tsa Chen;
- Helm, James;
- Kvols, Larry
Publication type:
Article
Current Status and Perspectives of Targeted Therapy in Well-Differentiated Neuroendocrine Tumors.
Published in:
Oncology, 2012, v. 83, n. 3, p. 117, doi. 10.1159/000339539
By:
- Naraev, Boris G.;
- Strosberg, Jonathan R.;
- Halfdanarson, Thorvardur R.
Publication type:
Article
The Evolving Treatment Algorithm for Advanced Neuroendocrine Neoplasms: Diversity and Commonalities Across Tumor Types.
Published in:
Oncologist, 2019, v. 24, n. 1, p. 54, doi. 10.1634/theoncologist.2018-0187
By:
- Hendifar, Andrew E.;
- Dhall, Deepti;
- Strosberg, Jonathan R.
Publication type:
Article
Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study.
Published in:
2014
By:
- Strosberg, Jonathan R.;
- Benson, Al B.;
- Huynh, Lynn;
- Duh, Mei Sheng;
- Goldman, Jamie;
- Sahai, Vaibhav;
- Rademaker, Alfred W.;
- Kulke, Matthew H.
Publication type:
Journal Article
Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study.
Published in:
Oncologist, 2014, v. 19, n. 9, p. 930, doi. 10.1634/theoncologist.2014-0120
By:
- Strosberg, Jonathan R.;
- Benson, Al B.;
- Huynh, Lynn;
- Duh, Mei Sheng;
- Goldman, Jamie;
- Sahai, Vaibhav;
- Rademaker, Alfred W.;
- Kulke, Matthew H.
Publication type:
Article
Phase 1 dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors.
Published in:
OncoTargets & Therapy, 2017, v. 10, p. 3177, doi. 10.2147/OTT.S128547
By:
- Yao, James C.;
- Chan, Jennifer A.;
- Mita, Alain C.;
- Kundu, Madan G.;
- Reséndiz, Karina Hermosillo;
- Ke Hu;
- Ravichandran, Shoba;
- Strosberg, Jonathan R.;
- Wolin, Edward M.
Publication type:
Article
Familial Gastrointestinal Stromal Tumor Syndrome: Report of 2 Cases With KIT Exon 11 Mutation.
Published in:
Cancer Control: Journal of the Moffitt Cancer Center, 2015, v. 22, n. 1, p. 102, doi. 10.1177/107327481502200113
By:
- Jones, Derek H.;
- Caracciolo, Jamie T.;
- Hodul, Pamela J.;
- Strosberg, Jonathan R.;
- Coppola, Domenico;
- Bui, Marilyn M.
Publication type:
Article
Preclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 11, p. 3408, doi. 10.1007/s00259-021-05315-1
By:
- Tafreshi, Narges K.;
- Pandya, Darpan N.;
- Tichacek, Christopher J.;
- Budzevich, Mikalai M.;
- Wang, Zhen;
- Reff, Jordan N.;
- Engelman, Robert W.;
- Boulware, David C.;
- Chiappori, Alberto A.;
- Strosberg, Jonathan R.;
- Ji, Haitao;
- Wadas, Thaddeus J.;
- El-Haddad, Ghassan;
- Morse, David L.
Publication type:
Article
Gastroenteropancreatic Neuroendocrine Tumors.
Published in:
2018
By:
- Cives, Mauro;
- Strosberg, Jonathan R.
Publication type:
journal article

Found: 39

A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms.

The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine Neoplasms.

Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS).

Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.

Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors.

Cardiac Magnetic Resonance for Diagnosis of Neuroendocrine Tumor Metastases to the Right and Left Ventricles with Carcinoid Heart Disease.

EGFR is a potential therapeutic target for highly glycosylated and aggressive pancreatic neuroendocrine neoplasms.

EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumor.

Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials.

Sequencing of Somatostatin-Receptor-Based Therapies in Neuroendocrine Tumor Patients.

Sequencing of Somatostatin-Receptor--Based Therapies in Neuroendocrine Tumor Patients.

Sequencing of Somatostatin-Receptor--Based Therapies in Neuroendocrine Tumor Patients.

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATE.

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATE.

Reply: Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy.

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATE.

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATE.

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATE.

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATE.

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with <sup>177</sup>Lu-DOTATATE.

Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).

Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).

Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).

Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).

Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).

Risk of bowel obstruction in patients with mesenteric/peritoneal disease receiving peptide receptor radionuclide therapy (PRRT).

Medical Management of Gastroenteropancreatic Neuroendocrine Tumors: Current Strategies and Future Advance.

NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE.

Medical Management of Gastroenteropancreatic Neuroendocrine Tumors: Current Strategies and Future Advances.

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.

First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas.

Current Status and Perspectives of Targeted Therapy in Well-Differentiated Neuroendocrine Tumors.

The Evolving Treatment Algorithm for Advanced Neuroendocrine Neoplasms: Diversity and Commonalities Across Tumor Types.

Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study.

Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study.

Phase 1 dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors.

Familial Gastrointestinal Stromal Tumor Syndrome: Report of 2 Cases With KIT Exon 11 Mutation.

Preclinical evaluation of [<sup>225</sup>Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms.

Gastroenteropancreatic Neuroendocrine Tumors.